Article Versions Notes

Sarkar A, Gallo MC, Bell JA, Mayfield CK, Ball JR, Ayad M, Lechtholz-Zey E, Chang SW, Sugiyama O, Evseenko D, et al. Ex Vivo Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing Study. Bioengineering. 2025; 12(1):29. https://doi.org/10.3390/bioengineering12010029

Sarkar, Arijita, Matthew C. Gallo, Jennifer A. Bell, Cory K. Mayfield, Jacob R. Ball, Mina Ayad, Elizabeth Lechtholz-Zey, Stephanie W. Chang, Osamu Sugiyama, Denis Evseenko, and et al. 2025. "Ex Vivo Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing Study" Bioengineering 12, no. 1: 29. https://doi.org/10.3390/bioengineering12010029

Sarkar, A., Gallo, M. C., Bell, J. A., Mayfield, C. K., Ball, J. R., Ayad, M., Lechtholz-Zey, E., Chang, S. W., Sugiyama, O., Evseenko, D., & Lieberman, J. R. (2025). Ex Vivo Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing Study. Bioengineering, 12(1), 29. https://doi.org/10.3390/bioengineering12010029